FDA clearance is necessary but complicated.
“It is no small task to be a medical device company, build this infrastructure, build all the standard operating procedures that the FDA wants to see,” says Movano Health CEO John Mastrototaro, whose company is working on making an FDA-cleared smart ring for consumers.
When I caught up with Mastrototaro at this year’s CES, he wasn’t fazed much. Instead, he pointed to the fact that the ring — now called Evie, short for “evidence”— successfully passed a hypoxia trial in October 2022, showing clinical-level accuracy for heart rate and oxygen saturation measurements. The FDA, Mastrototaro says, requires accuracy across a broad range of oxygen levels with a margin of error of 4 percent. That has to be tested for women, men, and people of all skin tones.
But if successful, the Evie Ring would be one of the first consumer wearables fully cleared as a medical device.FDA clearance may also be the only way a company can get novel health tech into the hands of consumers. For the past, Valencell — a wearable tech provider to companies like LG, Jabra, and Bose — has been at CES showcasing its noninvasive blood pressure monitoring tech using photoplethysmography sensors.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Increasingly Halting Human Trials as Companies Pursue Risky, Cutting-Edge DrugsThe agency is placing more holds on trials to protect patients and ensure studies are designed properly, a Wall Street Journal review found.
Read more »
FDA approves new Alzheimer’s drug, but its price tag is raising concerns among advocatesA new breakthrough Alzheimer's drug is giving people hope, but the cost is raising concern among advocates.
Read more »
FDA paused trials for experimental drugs more often in recent yearsThe Food and Drug Administration has increasingly exercised its power to delay drug companies' testing of experimental drugs in recent years, a possible byproduct of newer medical technologies that offer promise but may pose additional risks.
Read more »
FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug AduhelmFDA Commissioner Robert Califf defended the decision to approve the controversial Alzheimer’s drug Aduhelm after a congressional probe found “inappropriate” collaboration between the agency and Biogen
Read more »
Big food brands take 'disappointing' workaround after FDA's sesame seed announcementThe Fox News Lifestyle Newsletter brings you trending stories on family, travel, food, neighbors helping neighbors, pets, autos, military veterans, heroes, faith and American values.
Read more »
A new FDA-approved Alzheimer's medicine slowed cognitive decline in patientsThe US FDA approved Leqembi, a new drug that is intended to slow down cognitive decline in patients who have mild or early-stage Alzheimer's disease.
Read more »